Cross Country Healthcare Confirms Acquisition by Knox Lane, Reports Weak Q1 Earnings, Cancels Call
CCRN sits 76% above its 52-week low of $7.43 on elevated volume (10× avg).
Summary
Cross Country Healthcare confirmed its definitive merger agreement with Knox Lane for $13.25 per share, while simultaneously reporting weak first-quarter financial results and canceling its earnings call due to the pending acquisition.
Key Events · M&A and Partnerships · CCRN
-
Definitive Merger Agreement Confirmed
The company confirmed it has entered into a definitive agreement to be acquired by Knox Lane for $13.25 per share in an all-cash transaction. This follows the initial announcement of the acquisition on May 6, 2026, and an earlier 8-K filing today.
-
Weak Q1 2026 Financial Results Reported
Cross Country Healthcare announced first-quarter 2026 revenue of $241.1 million, an 18% decrease year-over-year. The company reported a net loss of $4.3 million and diluted EPS of $(0.14), significantly worse than the prior year.
-
Earnings Conference Call Canceled
Due to the pending merger, the company canceled its scheduled earnings conference call to discuss first-quarter 2026 financial results, signaling the finality of the acquisition.
-
Share Repurchase Activity
During the first quarter of 2026, the company repurchased 0.7 million shares of its common stock for an aggregate price of $5.8 million, at an average market price of $8.86 per share.
Analysis · CCRN · Trade & Services
This filing confirms the definitive merger agreement for Cross Country Healthcare to be acquired by Knox Lane for $13.25 per share, reiterating the major news previously disclosed. Concurrently, the company reported weak first-quarter 2026 financial results, including significant year-over-year declines in revenue, net loss, and Adjusted EBITDA. The scheduled earnings conference call was canceled due to the pending acquisition, underscoring the imminent change in company ownership. Despite the operational challenges, the acquisition provides a premium exit for shareholders, with the offer price slightly above the current market price.
At the time of this filing, CCRN was trading at $13.11 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $423.1M. The 52-week trading range was $7.43 to $14.99. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.